{"organizations": [], "uuid": "49b068c216f98e554c02368f834929b94b68d468", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/valeant-reports-profit-in-4th-quarter-on/valeant-reports-profit-in-4th-quarter-on-1-3-billion-tax-benefit-idUSL4N1QI5C8", "country": "US", "domain_rank": 408, "title": "Valeant reports profit in 4th quarter on $1.3 billion tax benefit", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-28T20:10:00.000+02:00", "replies_count": 0, "uuid": "49b068c216f98e554c02368f834929b94b68d468"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/valeant-reports-profit-in-4th-quarter-on/valeant-reports-profit-in-4th-quarter-on-1-3-billion-tax-benefit-idUSL4N1QI5C8", "ord_in_thread": 0, "title": "Valeant reports profit in 4th quarter on $1.3 billion tax benefit", "locations": [], "entities": {"persons": [{"name": "valeant", "sentiment": "negative"}, {"name": "manas mishra", "sentiment": "none"}, {"name": "sai sachin ravikumar", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "valeant pharmaceuticals", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - Valeant Pharmaceuticals on Wednesday reported a profit in the fourth quarter compared to a year-earlier loss, as it booked a one-time benefit because of new U.S. tax laws.\nThe Canada-based drugmaker reported a net income of $513 million or $1.45 per share in the quarter ended Dec. 31, compared to a loss of $515 million or $1.47 per share a year earlier.\nIt recorded a one-time benefit from income taxes of $1.32 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Sai Sachin Ravikumar)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T20:10:00.000+02:00", "crawled": "2018-03-01T21:25:12.023+02:00", "highlightTitle": ""}